Major Depressive Disorder Treatment Market Value Share, Supply by2026 FMI | страница 3

Report
Description
Report Description
Major Depressive Disorder (MDD) is one of the most common mental disorder characterized by
persistent and tenacious low mood that interferes with the person’s ability to work, eat, sleep
and normal activities. MDD is also referred as clinical depression, major depression, and
unipolar depression or as recurrent depression. The common symptoms associated with this
disorder include insomnia, loss of interest, recurrent thoughts of death, feelings of
worthlessness and reduced ability to think. Increasing number of patients suffering from MDD
has grabbed the attention of MDD drugs manufacturer to invest into MDD treatment market.
Major Depressive Disorder (MDD) Treatment Market: Drivers and Restraints
Work life imbalances due to change in life style, and increase in MDD patient pool are the key
drivers expected to drive the MDD treatment market over the forecasted period. Partnerships
for co-development and co-marketing of MDD drugs among the drug manufactures across the
globe, development of new drugs, and adequate government reimbursement policies have also
fueled the growth of MDD treatment market. However, stringent regulations imposed by various
governments for new drug approval, patent expiries of some blockbuster drugs, risk of
complications with other medications, and related side effects of MDD drugs may hinder the
growth of MDD treatment market over the forecasted period.
Request for sample report: http://www.futuremarketinsights.com/reports/sample/rep-gb-1314